trial

Assessing the Effectiveness of Acceptance and Commitment Therapy for Distress Following Psychosis

NCTId NCT01003132
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 27 (actual)
Sponsored by University of Glasgow
Primary completion 2010-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
27 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2009-10
Primary completion
2010-10
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Acceptance and Commitment Therapy

Sponsors

University of GlasgowLead Sponsor
NHS Greater Glasgow and ClydeCollaborator

Investigators

1
Ross G White, BSc, PhD, DClinPsyPrincipal Investigator

Sites

1 total
Glasgow, United Kingdom

Facts & assertions

4 sourced
Enrollment
27
Phase
NA
Primary Completion Date
2010-10
Status
COMPLETED
relationships
The graph out of here
drug
Acceptance and Commitment Therapy
drug
lead_sponsor
University of Glasgow
company
collaborator
NHS Greater Glasgow and Clyde
company
indication
Bipolar Disorder
indication
Schizo-affective Disorder
indication
Psychosis
indication
investigator
Ross G White, BSc, PhD, DClinPsy
person